Xeris Biopharma Holdings Inc

-0.08 (-4.00%)
Earnings Announcements

Xeris Pharmaceuticals Reports Q4 Loss Per Share $0.41

Published: 03/09/2021 12:45 GMT
Xeris Biopharma Holdings Inc (XERS) - Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights.
Q4 Loss per Share $0.41.
Q4 Earnings per Share Estimate $-0.38 -- Refinitiv Ibes Data (analyst estimates).
Xeris Pharmaceuticals - As of Dec 31, 2020, Reported Total Cash, Equivalents, Investments of $133.8 Million.
Revenue is expected to be $11.01 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $11.34 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.